Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Quality of Life (QoL) Between Trabectedin/PLD and Standard Platinum-based Therapy in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Peritoneal Cancer

NCT03164980 is registered in ClinicalTrials.gov with North Eastern German Society of Gynaecological Oncology as lead sponsor.

NCT NCT03164980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03164980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Quality of Life (QoL) Between Trabectedin/PLD and Standard Platinum-based Therapy in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Peritoneal Cancer
Lead sponsor
North Eastern German Society of Gynaecological Oncology
Phase
Phase 4
Overall status
Terminated
Start date
February 1, 2018
Completion date
August 8, 2023
Enrollment
89 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer, quality of life, recurrent ovarian carcinoma